Joel Greenblatt - Gotham Asset Management
Holding/activity history for Xeris Biopharma Holdings, Inc. (XERS)
← All XERS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 43,257 | <0.01 | Add 22.15% | <0.01 | $5.25–8.42 · VW $6.60i | $250,891 | SEC |
| 2025 Q4 | 35,412 | <0.01 | Reduce 17.15% | <0.01 | $6.47–10.08 · VW $7.84i | $277,984 | SEC |
| 2025 Q3 | 42,741 | <0.01 | Add 30.44% | <0.01 | $4.62–8.51 · VW $6.86i | $347,912 | SEC |
| 2025 Q2 | 32,766 | <0.01 | Add 101.86% | <0.01 | $3.81–5.28 · VW $4.58i | $153,017 | SEC |
| 2025 Q1 | 16,232 | <0.01 | Buy | <0.01 | $3.14–6.07 · VW $4.44i | $89,114 | SEC |
Price snapshot:
Current price$8.16
Avg. buy price$5.79
+/- since buy40.86%
52-week low$4.87
52-week high$10.08